Literature DB >> 2465492

The loss of subtypic determinants in alleles, d/y or w/r, on hepatitis B surface antigen.

H Okamoto1, S Omi, Y Wang, Y Itoh, F Tsuda, T Tanaka, Y Akahane, Y Miyakawa, M Mayumi.   

Abstract

Hepatitis B surface antigen possesses the group-specific determinant called a and one or another member from each of two pairs of allelic determinants, d and y as well as w and r, thereby creating the four major subtypes, adw, adr, ayw and ayr. In the sequence of major surface antigen polypeptides made of 226 amino acid residues, lysine or arginine at amino acid position 122 specifies d or y determinant, and lysine or arginine at position 160 specifies w or r determinant, respectively. By means of site-directed mutagenesis and expression of mutant genes in cultured cells, the mechanism for the loss of subtypic determinants on surface antigens was investigated at the molecular level. A rare sample of surface antigen of subtype ad, devoid of w or r determinant, had asparagine at position 160. When it was converted to lysine, the surface antigen of subtype adw was obtained. Two samples of surface antigen were subtyped as ar. They lacked d determinant, despite having lysine at position 122 which usually specified it. They differed from all reported sequences of surface antigen in amino acid 144 or 145. They displayed d determinant when amino acid 144 was converted from glutamic acid to aspartic acid, or when amino acid 145 was changed from alanine to glycine. These results indicate that the key amino acid residue at position 122 or 160 is indispensable for the expression of subtypic determinants and that some distant residues are also crucially involved in conforming them.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465492     DOI: 10.1016/0161-5890(89)90102-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil.

Authors:  M T Moraes; S A Gomes; C Niel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

3.  Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.

Authors:  J Hayashi; A Noguchi; K Nakashima; M Morofuji; S Kashiwagi
Journal:  Gastroenterol Jpn       Date:  1990-10

4.  Strain analysis of hepatitis B virus on the basis of restriction endonuclease analysis of polymerase chain reaction products.

Authors:  J W Shih; L C Cheung; H J Alter; L M Lee; J R Gu
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

5.  HBsAg subtype distribution among different populations of HBsAg carriers in Spain.

Authors:  J E Echevarría; P León; J A López; A Tenorio; C J Domingo; J M Echevarría
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

6.  Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen.

Authors:  G Borisova; B Arya; A Dislers; O Borschukova; V Tsibinogin; D Skrastina; M A Eldarov; P Pumpens; K G Skryabin; E Grens
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r.

Authors:  H Ohnuma; A Machida; H Okamoto; F Tsuda; M Sakamoto; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

9.  HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining.

Authors:  Xizhan Xu; Kuanhui Xiang; Mingze Su; Yao Li; Wei Ji; Yutang Li; Hui Zhuang; Tong Li
Journal:  Viruses       Date:  2017-07-27       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.